Sören Andersson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sören Andersson has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Edward Kumakech
Affiliation Department of Nursing, Faculty of Nursing and Midwifery, Lira University, Lira, Uganda
3 shared publications - Henry Wabinga
Kampala Cancer Registry, Department of Pathology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda
3 shared publications - Vanja Berggren
Karolinska Institute, Sweden
3 shared publications F. Dias
National Public Health Laboratory, Bissau, Guinea-Bissau
2 shared publicationsG. Biberfeld
Swedish Institute for Infectious Disease Control and the Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden
2 shared publications- Hans Norrgren
Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden
2 shared publications
Latest Publications
- Open Access
- 2 June 2017
- Published by Springer Nature in BMC Women's Health
- Vol. 17 (1) , 1-12
Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study
Previous studies were conflicting regarding the associations between HPV vaccination, cervical cancer risk perceptions, high-risk sexual behaviors and STIs. This study compared the HPV-vaccinated and non-vaccinated young women in Uganda regarding cervical cancer risk perceptions, high-risk sexual behaviors, syphilis and HIV infections 5 years after vaccine implementation. This was a population-based comparative cross-sectional survey conducted in Uganda. The 438 participants were sexually active young women aged 15–24 years and mean age was 18.6 (SD 1.4). The majority (53.0%) were HPV-vaccinated in 2008 without assessment of sexual activity prior to HPV vaccination. Upon verbal assessment of sexual activity at the time of follow-up, data were collected using a questionnaire and laboratory testing of blood samples for syphilis and HIV infections. There were no significant differences between the HPV-vaccinated and non-vaccinated groups regarding the prevalence of high-risk sexual behaviors, syphilis and HIV infections. Cervical cancer risk perceptions and age at sexual debut were nonetheless significantly lower among the vaccinated group compared to their non-vaccinated counterparts. However, HPV vaccination was not significantly associated to cervical cancer risk perceptions and early age at sexual debut in multivariate logistic regression analysis. We found no associations between HPV vaccination, cervical cancer risk perceptions, high-risk sexual behaviors, syphilis and HIV infections among young women in Uganda 5 years after vaccine implementation. Young girls in the study population were found to be sexually active at a young age, affirming the importance of targeting girls of younger age for HPV vaccination.
- 2 June 2017
- Published by Springer Nature in BMC Women's Health
- Vol. 17 (1) , 1-12
Open AccessCervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study
Previous studies were conflicting regarding the associations between HPV vaccination, cervical cancer risk perceptions, high-risk sexual behaviors and STIs. This study compared the HPV-vaccinated and non-vaccinated young women in Uganda regarding cervical cancer risk perceptions, high-risk sexual behaviors, syphilis and HIV infections 5 years after vaccine implementation. This was a population-based comparative cross-sectional survey conducted in Uganda. The 438 participants were sexually active young women aged 15–24 years and mean age was 18.6 (SD 1.4). The majority (53.0%) were HPV-vaccinated in 2008 without assessment of sexual activity prior to HPV vaccination. Upon verbal assessment of sexual activity at the time of follow-up, data were collected using a questionnaire and laboratory testing of blood samples for syphilis and HIV infections. There were no significant differences between the HPV-vaccinated and non-vaccinated groups regarding the prevalence of high-risk sexual behaviors, syphilis and HIV infections. Cervical cancer risk perceptions and age at sexual debut were nonetheless significantly lower among the vaccinated group compared to their non-vaccinated counterparts. However, HPV vaccination was not significantly associated to cervical cancer risk perceptions and early age at sexual debut in multivariate logistic regression analysis. We found no associations between HPV vaccination, cervical cancer risk perceptions, high-risk sexual behaviors, syphilis and HIV infections among young women in Uganda 5 years after vaccine implementation. Young girls in the study population were found to be sexually active at a young age, affirming the importance of targeting girls of younger age for HPV vaccination.
- Open Access
- 11 March 2015
- Published by Springer Nature in BMC Women's Health
- Vol. 15 (1) , 23
Integration of HIV and cervical cancer screening perceptions and preferences of communities in Uganda
Despite the fact that HIV-positive women carry an increased risk of developing cervical cancer (CC) in comparison with HIV-negative women, HIV and CC screening programs in many developing countries have remained unintegrated. The objective of this study is to explore perceptions and preferences of community members in Uganda, including women, men, and village health teams, regarding the integration of HIV and CC screening services in a single-visit approach. This qualitative study was conducted in three districts in Uganda. Data were collected through focus group discussions with women and village health teams, and individual interviews with men. Respondents were purposely selected from among those linked to three CC clinics in the three districts. The content analysis method was used to analyze the data. Three themes emerged from the data, namely appreciating the benefits of integration, worrying about the challenges of integration, and preferences for integration. The women endorsed the benefits. However, there were worries that integration would prolong the waiting time at the health facility and induce tiredness in both the healthcare providers and the women. There were also fears of being found positive for both HIV and CC and the consequences such as stress, self-isolation, and social conflicts. Participants, particularly the women, considered the challenges of screening integration to be manageable by, for example, taking a day off work to visit the hospital, delegating house chores to other family members, or taking a packed lunch on visiting the hospital. The community members in Uganda perceive the benefits of HIV and CC screening integration to outweigh the challenges, and expect that the challenges can be minimized or managed by the women. Therefore, when considering HIV and CC screening integration, it is important to not only recognize the benefits but also take into consideration the perceived challenges and preferences of community members.
- 11 March 2015
- Published by Springer Nature in BMC Women's Health
- Vol. 15 (1) , 23
Open AccessIntegration of HIV and cervical cancer screening perceptions and preferences of communities in Uganda
Despite the fact that HIV-positive women carry an increased risk of developing cervical cancer (CC) in comparison with HIV-negative women, HIV and CC screening programs in many developing countries have remained unintegrated. The objective of this study is to explore perceptions and preferences of community members in Uganda, including women, men, and village health teams, regarding the integration of HIV and CC screening services in a single-visit approach. This qualitative study was conducted in three districts in Uganda. Data were collected through focus group discussions with women and village health teams, and individual interviews with men. Respondents were purposely selected from among those linked to three CC clinics in the three districts. The content analysis method was used to analyze the data. Three themes emerged from the data, namely appreciating the benefits of integration, worrying about the challenges of integration, and preferences for integration. The women endorsed the benefits. However, there were worries that integration would prolong the waiting time at the health facility and induce tiredness in both the healthcare providers and the women. There were also fears of being found positive for both HIV and CC and the consequences such as stress, self-isolation, and social conflicts. Participants, particularly the women, considered the challenges of screening integration to be manageable by, for example, taking a day off work to visit the hospital, delegating house chores to other family members, or taking a packed lunch on visiting the hospital. The community members in Uganda perceive the benefits of HIV and CC screening integration to outweigh the challenges, and expect that the challenges can be minimized or managed by the women. Therefore, when considering HIV and CC screening integration, it is important to not only recognize the benefits but also take into consideration the perceived challenges and preferences of community members.
- Open Access
- 7 August 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 810
Integration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda
HIV-positive women have an increased risk of developing cervical cancer (CC) compared to the HIV-negative women. Despite this, HIV and CC screening programs in many developing countries have remained disintegrated. Therefore, the objective of the study was to explore perceptions of healthcare providers (HCP) and policy makers (PM) about integration of HIV and CC screening services in Uganda. This was a qualitative study conducted among 16 participants comprising of 12 healthcare providers and 4 policy makers in Uganda. Data were collected through individual interviews. Participants were purposively selected from different level of health facilities with clinics for HIV and CC screening services. Content analysis method was used to analyze the data. Three themes emerged from the data, namely appreciating benefits of integration, worrying about the limited health system capacity and potential consequences of integration and feeling optimistic about integration under improved health system conditions. The benefits embraced the women – particularly the HIV-positive women- but also men, healthcare providers and the health system or the government. There were worries that HIV stigma and shortage of healthcare workers would affect the effective delivery of the integrated program. Integration of HIV and CC screening can offer manifold benefits to all stakeholders in the health system, more so to the women. However, its feasibility in developing countries such as Uganda will most likely be hampered by weak and inefficient health systems. Therefore, when considering HIV and CC screening integration, it is important not to only recognize the benefits but also take into account resources requirements for addressing the existing weaknesses and inefficiencies in the health systems such as limited infrastructure, insufficient drugs and supplies, inadequate and poorly motivated healthcare workers.
- 7 August 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 810
Open AccessIntegration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda
HIV-positive women have an increased risk of developing cervical cancer (CC) compared to the HIV-negative women. Despite this, HIV and CC screening programs in many developing countries have remained disintegrated. Therefore, the objective of the study was to explore perceptions of healthcare providers (HCP) and policy makers (PM) about integration of HIV and CC screening services in Uganda. This was a qualitative study conducted among 16 participants comprising of 12 healthcare providers and 4 policy makers in Uganda. Data were collected through individual interviews. Participants were purposively selected from different level of health facilities with clinics for HIV and CC screening services. Content analysis method was used to analyze the data. Three themes emerged from the data, namely appreciating benefits of integration, worrying about the limited health system capacity and potential consequences of integration and feeling optimistic about integration under improved health system conditions. The benefits embraced the women – particularly the HIV-positive women- but also men, healthcare providers and the health system or the government. There were worries that HIV stigma and shortage of healthcare workers would affect the effective delivery of the integrated program. Integration of HIV and CC screening can offer manifold benefits to all stakeholders in the health system, more so to the women. However, its feasibility in developing countries such as Uganda will most likely be hampered by weak and inefficient health systems. Therefore, when considering HIV and CC screening integration, it is important not to only recognize the benefits but also take into account resources requirements for addressing the existing weaknesses and inefficiencies in the health systems such as limited infrastructure, insufficient drugs and supplies, inadequate and poorly motivated healthcare workers.
- Open Access
- 6 June 2011
- Published by Springer Nature in Retrovirology
- Vol. 8 (S1) , A67
HTLV-2 infection still prevalent among older injecting drug users in Stockholm, Sweden – indications of limited spread to the younger generation
- 6 June 2011
- Published by Springer Nature in Retrovirology
- Vol. 8 (S1) , A67
Open AccessHTLV-2 infection still prevalent among older injecting drug users in Stockholm, Sweden – indications of limited spread to the younger generation
- 26 January 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 139 (3) , 483-489
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau
Summary: Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses were determined in cultures of peripheral blood mononuclear cells from HIV-2-exposed uninfected individuals, HIV-2-infected individuals and HIV-negative controls in Guinea-Bissau. Increased HIV-2-specific T lymphocyte proliferative responses were detected in both groups compared to HIV-negative controls (healthy HIV-uninfected individuals without known exposure to an HIV-infected person); five out of 29 of the HIV-2-exposed uninfected and half (16 of 32) of the HIV-2-infected individuals had stimulation indexes >2, compared to one out of 49 of the HIV-negative controls (P = 0·003 and P < 0·0001, respectively). The exposed uninfected individuals had reactivity to a HIV-2 V3-peptide corresponding to amino acids 311–326 of the envelope glycoprotein, while the HIV-2-infected people reacted mainly to HIV-2 whole viral lysate. Thus, this study demonstrates a high degree of HIV-2-specific T helper cell activity, as measured by lymphocyte proliferation, in HIV-2-exposed uninfected individuals as well as in HIV-2-infected subjects. These immune responses could be important for resistance to the infection and for the control of established infection and, thus, play a role in the lower transmission and progression of HIV-2 compared to HIV-1.
- 26 January 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 139 (3) , 483-489
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau
Summary: Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses were determined in cultures of peripheral blood mononuclear cells from HIV-2-exposed uninfected individuals, HIV-2-infected individuals and HIV-negative controls in Guinea-Bissau. Increased HIV-2-specific T lymphocyte proliferative responses were detected in both groups compared to HIV-negative controls (healthy HIV-uninfected individuals without known exposure to an HIV-infected person); five out of 29 of the HIV-2-exposed uninfected and half (16 of 32) of the HIV-2-infected individuals had stimulation indexes >2, compared to one out of 49 of the HIV-negative controls (P = 0·003 and P < 0·0001, respectively). The exposed uninfected individuals had reactivity to a HIV-2 V3-peptide corresponding to amino acids 311–326 of the envelope glycoprotein, while the HIV-2-infected people reacted mainly to HIV-2 whole viral lysate. Thus, this study demonstrates a high degree of HIV-2-specific T helper cell activity, as measured by lymphocyte proliferation, in HIV-2-exposed uninfected individuals as well as in HIV-2-infected subjects. These immune responses could be important for resistance to the infection and for the control of established infection and, thus, play a role in the lower transmission and progression of HIV-2 compared to HIV-1.
- 17 August 2001
- Published by Elsevier in Virus Research
- Vol. 78 (1-2) , 101-106
Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II
- 17 August 2001
- Published by Elsevier in Virus Research
- Vol. 78 (1-2) , 101-106
Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II
- Open Access
- 27 November 2000
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (21) , 3286-3293
Plasma Viral Load in HIV-1 and HIV-2 Singly and Dually Infected Individuals in Guinea-Bissau, West Africa
THE EPIDEMIOLOGICAL and biological characteristics of human immunodeficiency virus (HIV) 1 and HIV-2 exhibit major differences. Whereas HIV-2 is confined mainly to West Africa, HIV-1 is spread globally. Furthermore, the rates of disease progression and transmission are significantly lower in HIV-2 infection.1-4 The reasons for these important differences are not fully understood, but in 1993 De Kock and coworkers5 postulated that differences in viral load may be important. Quantification of HIV-1 plasma viral RNA levels has become widely used for monitoring patients and has been found to have a high prognostic value for clinical progression and response to antiretroviral treatment.6,7 Plasma HIV-1 levels reach a semi-equilibrium (set point, inflection point) after the initial burst of viral replication during primary infection, and this set point is the best available predictor of disease outcome. Commonly, the plasma HIV-1 RNA concentrations reach this lowest level 3 to 6 months after seroconversion and then slowly start to increase. The rate of this gradual increase is determined by the level of the set point.7-9 The information about HIV-2 viral load is limited, and no data on the set point of plasma HIV-2 RNA have been previously published. However, a study by Simon et al10 based on virus isolation and quantification of proviral DNA load in peripheral-blood mononuclear cells indicated that HIV-2–infected patients had significantly lower viral loads than HIV-1–infected patients at corresponding CD4+ T-cell levels. In contrast, a few other studies have shown that the levels of proviral HIV-2 DNA in peripheral-blood mononuclear cells are similar to those in comparable groups of HIV-1–infected individuals.11-13 Two recent studies provided data on plasma HIV-2 RNA levels.14,15 Using different in-house assays, both studies showed lower HIV-2 than HIV-1 plasma viral load in cross-sectional samples, but neither included seroincident cases tested early after seroconversion.
- 27 November 2000
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (21) , 3286-3293
Open AccessPlasma Viral Load in HIV-1 and HIV-2 Singly and Dually Infected Individuals in Guinea-Bissau, West Africa
THE EPIDEMIOLOGICAL and biological characteristics of human immunodeficiency virus (HIV) 1 and HIV-2 exhibit major differences. Whereas HIV-2 is confined mainly to West Africa, HIV-1 is spread globally. Furthermore, the rates of disease progression and transmission are significantly lower in HIV-2 infection.1-4 The reasons for these important differences are not fully understood, but in 1993 De Kock and coworkers5 postulated that differences in viral load may be important. Quantification of HIV-1 plasma viral RNA levels has become widely used for monitoring patients and has been found to have a high prognostic value for clinical progression and response to antiretroviral treatment.6,7 Plasma HIV-1 levels reach a semi-equilibrium (set point, inflection point) after the initial burst of viral replication during primary infection, and this set point is the best available predictor of disease outcome. Commonly, the plasma HIV-1 RNA concentrations reach this lowest level 3 to 6 months after seroconversion and then slowly start to increase. The rate of this gradual increase is determined by the level of the set point.7-9 The information about HIV-2 viral load is limited, and no data on the set point of plasma HIV-2 RNA have been previously published. However, a study by Simon et al10 based on virus isolation and quantification of proviral DNA load in peripheral-blood mononuclear cells indicated that HIV-2–infected patients had significantly lower viral loads than HIV-1–infected patients at corresponding CD4+ T-cell levels. In contrast, a few other studies have shown that the levels of proviral HIV-2 DNA in peripheral-blood mononuclear cells are similar to those in comparable groups of HIV-1–infected individuals.11-13 Two recent studies provided data on plasma HIV-2 RNA levels.14,15 Using different in-house assays, both studies showed lower HIV-2 than HIV-1 plasma viral load in cross-sectional samples, but neither included seroincident cases tested early after seroconversion.
- 1 August 1999
- Published by Wiley in Transfusion
- Vol. 39 (8) , 845-851
Comparative evaluation of 14 immunoassays for detection of antibodies to the human T‐lymphotropic virus types I and II using panels of sera from Sweden and West Africa
BACKGROUND: A new generation of assays for the detection of human T‐lymphotropic virus types I and II (HTLV‐I/II) antibodies has been released. These assays incorporate HTLV‐I‐ and HTLV‐II‐specific a...
- 1 August 1999
- Published by Wiley in Transfusion
- Vol. 39 (8) , 845-851
Comparative evaluation of 14 immunoassays for detection of antibodies to the human T‐lymphotropic virus types I and II using panels of sera from Sweden and West Africa
BACKGROUND: A new generation of assays for the detection of human T‐lymphotropic virus types I and II (HTLV‐I/II) antibodies has been released. These assays incorporate HTLV‐I‐ and HTLV‐II‐specific a...